Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice

Journal of Lipid Research

Volumn 43, Issue 3, 2002, Pages 477-485

  Forte, Trudy M ^a   Subbanagounder, Ganesamoorthy ^b   Berliner, Judith A ^b   Blanche, Patricia J ^a   Clermont, Anne O ^a   Jia, Zhen ^a   Oda, Michael N ^a   Krauss, Ronald M ^a   Bielicki, John K ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ApoE deficient mice; Atherogenic diet; Bioactive oxidized phospholipids; High density lipoproteins; LDL receptor deficient mice

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 1 PALMITOYL 2 GLUTARYLGLYCERO 3 PHOSPHOCHOLINE; 1 PALMITOYL 2 OXOVALERYLGLYCERO 3 PHOSPHOCHOLINE; APOLIPOPROTEIN E; ARYLDIALKYLPHOSPHATASE; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENOTYPE; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; ARYLDIALKYLPHOSPHATASE; DIET; ESTERASES; GENETIC PREDISPOSITION TO DISEASE; LIPIDS; LIPOPROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; RECEPTORS, LDL; RNA, MESSENGER;

EID: 0036208796     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Minimally oxidized LDL is a potent inhibitor of lecithin: Cholesterol acyltransferase activity
2. Phospholipid hydroperoxides inhibit plasma lecithin: Cholesterol acyltransferase activity
3. Two novel molecular defects in the LCAT gene are associated with Fish Eye Disease
4. Overexpression of lecithin: Cholesterol acyltransferase in transgenic rabbits prevents diet-induced athersoclerosis
5. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin:cholesterl acyltransferase
6. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
7. Human serum paraoxonase/arylesterase
8. Protection of low-density lipoprotein against oxidative modification of high-density lipoprotein associated paraoxonase
9. HDL, its enzymes and its potential to influence lipid peroxidation
10. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
11. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model
12. Mice lacking serum paraoxonase are susceptible to organophosphatetoxicity and atherosclerosis
13. Combined serum paraoxonase knock-out/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
14. Paraoxonase and atherosclerosis
15. Platelet-activating factor acetylhydrolases
16. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: Influence on LDL oxidative susceptibility
17. Targeted disruption of the murine LCAT gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration
18. The mouse plasma PAF acetlhydrolase: II. It consists of two enzymes both associated with the HDL
19. Human plasma platelet-activating factor acetylhydrolase. Oxidatively fragmented phospholipids as substrates
20. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
21. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
22. Hypercholesterolemia and low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
23. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase
24. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase
25. Purification of human serum paraoxonase/arylesterase
26. Characterization of proteoliposomes containing apoprotein A-I: A new substrate for the measurement of lecithin: Cholesterol acyltransferase activity
27. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
28. Structural identification of a novel pro-inflammatory, epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein
29. Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-position
30. The use of TaqMan RT-PCR assays for semiquantitative analysis of gene expression in CNS tissues and disease models
31. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins
32. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
33. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction
34. Glycation impairs high-density lipoprotein function
35. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
36. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: A potential new risk factor for coronary artery disease
37. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease
38. Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan
39. -/- mice
40. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase
41. Novel function of lecithin:cholesterol acyltransferase: Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation
42. Lecithin: Cholesterol acyltransferase deficiency and fish-eye disease
43. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase
44. Role of sphingomyelin in the regulation of cholesterol esterification in the plasma lipoproteins: Inhibition of lecithin-cholesterol acyltransferase reaction
45. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity
46. Cysteine substitutions in apolipoprotein a-i primary structure modulate paraoxonase activity
47. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R
48. Human macrophages secrete platelet-activating factor acetylhydrolase
49. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
50. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation